Combination Therapy with Sulfasalazine and Valproic Acid Promotes Human Glioblastoma Cell Death Through Imbalance of the Intracellular Oxidative Response

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Molecular Neurobiology

• Publication date

  2018-01-19

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s12035-018-0895-1PMID 29349577
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic significance of E-cadherin and N-cadherin expression in Gliomas

  2017cited by this paper
• Low Dose of Doxorubicin Potentiates the Effect of Temozolomide in Glioblastoma Cells

  2017cited by this paper
• Seizures and gliomas — towards a single therapeutic approach

  2016cited by this paper
• Current and future strategies for treatment of glioma

  2016cited by this paper
• The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma.

  2016cited by this paper
• The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

  2016cited by this paper
• Scaffold Repurposing of Old Drugs Towards New Cancer Drug Discovery.

  2016cited by this paper
• Epithelial-mesenchymal transition in glioblastoma progression

  2016cited by this paper
• Mitotic catastrophe and cancer drug resistance: A link that must to be broken.

  2016cited by this paper
• Antiepileptic drugs in patients with malignant brain tumor: beyond seizures and pharmacokinetics

  2016cited by this paper
• A guide for the analysis of long-term population growth in cancer

  2016cited by this paper
• Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma.

  2016cited by this paper
• Early changes in system [Formula: see text] and glutathione in the retina of diabetic rats.

  2016cited by this paper
• Pharmacokinetics and Clinical Utility of Valproic Acid Administered via Continuous Infusion

  2015cited by this paper
• Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs.

  2015cited by this paper
• A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients With Glioblastoma.

  2015cited by this paper
• Targeting the Mitotic Catastrophe Signaling Pathway in Cancer

  2015cited by this paper
• Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc−, leading to glutathione depletion

  2015cited by this paper
• Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.

  2015cited by this paper
• Towards automatic image analysis and assessment of the multicellular apoptosis process

  2015cited by this paper
• Cellular and Molecular Connections between Autophagy and Inflammation

  2015cited by this paper
• Vitamin C Transporters, Recycling and the Bystander Effect in the Nervous System: SVCT2 versus Gluts

  2014cited by this paper
• Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.

  2014cited by this paper
• P17.47COMPREHENSIVE PROTEOMIC PROFILING OF BEVACIZUMAB-RESISTANT GLIOBLASTOMA MULTIFORME

  2014cited by this paper
• Very rare diseases in oncology

  2014cited by this paper
• The oxidized form of vitamin C, dehydroascorbic acid, regulates neuronal energy metabolism

  2014cited by this paper
• Histone deacetylase inhibitors in glioblastoma: pre-clinical and clinical experience

  2014cited by this paper
• Subcellular expression and neuroprotective effects of SK channels in human dopaminergic neurons

  2014cited by this paper
• Survival analysis for valproic acid use in adult glioblastoma multiforme: a meta-analysis of individual patient data and a systematic review.

  2014cited by this paper
• Inhibitory Activities of Trichostatin A in U87 Glioblastoma Cells and Tumorsphere-Derived Cells

  2014cited by this paper
• Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe

  2014cited by this paper
• Glioblastoma and other malignant gliomas: a clinical review.

  2013cited by this paper
• CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010.

  2013cited by this paper
• The Cystine/Glutamate Antiporter System xc − in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities

  2013cited by this paper
• CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.

  2012cited by this paper
• Astrocyte-induced Synaptogenesis Is Mediated by Transforming Growth Factor β Signaling through Modulation of d-Serine Levels in Cerebral Cortex Neurons*

  2012cited by this paper
• Valproic acid affected the survival and invasiveness of human glioma cells through diverse mechanisms

  2012cited by this paper
• Nuclear Morphometric Analysis (NMA): Screening of Senescence, Apoptosis and Nuclear Irregularities

  2012influential reference
• Valproic acid sensitizes human glioma cells for temozolomide and γ-radiation

  2012cited by this paper
• Vitamin C transport and its role in the central nervous system.

  2012cited by this paper
• Valproic acid inhibits angiogenesis in vitro and glioma angiogenesis in vivo in the brain.

  2012cited by this paper
• Abnormal Anatomical Connectivity between the Amygdala and Orbitofrontal Cortex in Conduct Disorder

  2012cited by this paper
• Glutamate Release by Primary Brain Tumors Induces Epileptic Activity

  2011cited by this paper
• The origins of glioma: E Pluribus Unum?

  2011cited by this paper
• Signal transduction inhibitors and antiangiogenic therapies for malignant glioma

  2011cited by this paper
• Valproic Acid Induced Differentiation and Potentiated Efficacy of Taxol and Nanotaxol for Controlling Growth of Human Glioblastoma LN18 and T98G Cells

  2011cited by this paper
• Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma

  2011cited by this paper
• Mitotic catastrophe: a mechanism for avoiding genomic instability

  2011cited by this paper
• Enhancement of temozolomide-induced apoptosis by valproic acid in human glioma cell lines through redox regulation

  2011cited by this paper
• Nitric Oxide Modulates Sodium Vitamin C Transporter 2 (SVCT-2) Protein Expression via Protein Kinase G (PKG) and Nuclear Factor-κB (NF-κB)*

  2011cited by this paper
• The glucose transporter-2 (GLUT2) is a low affinity dehydroascorbic acid transporter.

  2011cited by this paper
• Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012

  2011cited by this paper
• Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma.

  2010cited by this paper
• Pharmacogenomic Approach Reveals a Role for the xc− Cystine/Glutamate Antiporter in Growth and Celastrol Resistance of Glioma Cell Lines

  2010cited by this paper
• Homocysteine induces cytoskeletal remodeling and production of reactive oxygen species in cultured cortical astrocytes.

  2010cited by this paper
• Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines.

  2010cited by this paper
• Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers.

  2010cited by this paper
• Hypoxia Increases the Dependence of Glioma Cells on Glutathione*

  2010cited by this paper
• Glutamate receptors modulate sodium‐dependent and calcium‐independent vitamin C bidirectional transport in cultured avian retinal cells

  2009cited by this paper
• Genetic dissection of histone deacetylase requirement in tumor cells

  2009cited by this paper
• Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor‐κB

  2009influential reference
• Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2.

  2009cited by this paper
• Multiple roles of HDAC inhibition in neurodegenerative conditions.

  2009cited by this paper
• The x  c− cystine/glutamate antiporter: A potential target for therapy of cancer and other diseases

  2008cited by this paper
• Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo

  2008cited by this paper
• Valproic acid induces polarization, neuronal-like differentiation of a subpopulation of C6 glioma cells and selectively regulates transgene expression.

  2008cited by this paper
• Death through a tragedy: mitotic catastrophe

  2008cited by this paper
• The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?

  2007cited by this paper
• Valproic acid as anti-cancer drug.

  2007cited by this paper
• New uses for old drugs

  2007cited by this paper
• Valproic acid induces p21 and topoisomerase-II (α/β) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines

  2007cited by this paper
• Valproic acid induces p21 and topoisomerase-II (alpha/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines.

  2007cited by this paper
• Interactive properties of human glioblastoma cells with brain neurons in culture and neuronal modulation of glial laminin organization.

  2006cited by this paper
• Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies

  2006cited by this paper
• The Antiapoptotic Actions of Mood Stabilizers

  2005cited by this paper
• Valproate: a simple chemical with so much to offer

  2005cited by this paper
• Inhibition of Cystine Uptake Disrupts the Growth of Primary Brain Tumors

  2005influential reference
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials.

  2005cited by this paper
• In vitro and In vivo Activity of the Nuclear Factor-κB Inhibitor Sulfasalazine in Human Glioblastomas

  2004cited by this paper
• The Novel Neuroprotective Action of Sulfasalazine through Blockade of NMDA Receptors

  2003cited by this paper
• Azathioprine versus sulfasalazine in maintenance of remission in severe ulcerative colitis.

  2003cited by this paper
• Histone acetylation may suppress human glioma cell proliferation when p21 WAF/Cip1 and gelsolin are induced.

  2002cited by this paper
• Neurite outgrowth is impaired on HSP70-positive astrocytes through a mechanism that requires NF-kappaB activation.

  2002cited by this paper
• Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc− cystine transporter: a new action for an old drug

  2001cited by this paper
• Sulphasalazine and 5-aminosalicylic acid in long-term treatment of ulcerative colitis: report on tolerance and side-effects.

  2001cited by this paper
• Human vitamin C (L-ascorbic acid) transporter SVCT1.

  2000cited by this paper
• Dehydroascorbic acid transport by GLUT4 in Xenopus oocytes and isolated rat adipocytes.

  2000cited by this paper
• Glioma cells release excitotoxic concentrations of glutamate.

  1999cited by this paper
• Cloning and functional characterization of the human sodium‐dependent vitamin C transporters hSVCT1 and hSVCT2

  1999cited by this paper
• Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients.

  1999cited by this paper
• A family of mammalian Na+-dependent L-ascorbic acid transporters

  1999cited by this paper
• Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.

  1998cited by this paper
• Thyroid hormone action on astroglial cells fromdistinct brain regions during development

  1998cited by this paper
• Glucose Transporter Isoforms GLUT1 and GLUT3 Transport Dehydroascorbic Acid*

  1997cited by this paper
• Glutathione-ascorbic acid antioxidant system in animals.

  1994cited by this paper
• A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group.

  1992cited by this paper
• A mechanism for glutamate toxicity in the C6 glioma cells involving inhibition of cystine uptake leading to glutathione depletion.

  1992cited by this paper
• Exchange of cystine and glutamate across plasma membrane of human fibroblasts.

  1986cited by this paper
• Clinical Pharmacokinetics of Sulphasalazine, Its Metabolites and Other Prodrugs of 5-Aminosalicylic Acid

  1985cited by this paper

• Computational investigation of sulfasalazine adsorption on BN and CSi nanocages: Insights into drug-nanocarrier interactions in aqueous environment

  2025cites this paper
• Therapeutic and prognostic values of ferroptosis signature in glioblastoma.

  2025cites this paper
• Disrupted glutamate homeostasis as a target for glioma therapy

  2024cites this paper
• NOS2 and COX-2 Co-Expression Promotes Cancer Progression: A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast Cancer

  2024cites this paper
• Recent update on anti-tumor mechanisms of valproic acid in glioblastoma multiforme.

  2024cites this paper
• Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy

  2023cites this paper
• Ferroptosis of immune cells in the tumor microenvironment.

  2023cites this paper
• Emerging roles of ferroptosis in glioma

  2022cites this paper
• Ferroptosis Involvement in Glioblastoma Treatment

  2022cites this paper
• Quantitative measurement of peritumoral concentrations of glutamate, N-acetyl aspartate, and lactate on magnetic resonance spectroscopy predicts glioblastoma-related refractory epilepsy

  2022cites this paper
• A retrospective observational study on cases of anaplastic brain tumors treated with the Di Bella Method: A rationale and effectiveness

  2022cites this paper
• The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors?

  2021cites this paper
• Exploring the Pivotal Neurophysiologic and Therapeutic Potentials of Vitamin C in Glioma

  2021cites this paper
• Chemical hybridization of sulfasalazine and dihydroartemisinin promotes brain tumor cell death

  2021cites this paper
• Sulfasalazine, a potent suppressor of gastric cancer proliferation and metastasis by inhibition of xCT: Conventional drug in new use

  2021cites this paper
• Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy

  2021cites this paper
• Molecular docking-based virtual drug screening revealing an oxofluorenyl benzamide and a bromonaphthalene sulfonamido hydroxybenzoic acid as HDAC6 inhibitors with cytotoxicity against leukemia cells.

  2020cites this paper
• Short Survival-Related Genes Harbor EMT Processes and Dendritic Cell Infiltration in Glioblastoma

  2020cites this paper
• Sulfasalazine synergistically enhances the inhibitory effects of imatinib against hepatocellular carcinoma (HCC) cells by targeting NFκB, BCR/ABL, and PI3K/AKT signaling pathway‐related proteins

  2020cites this paper
• Vitamin K3 chloroderivative (VKT-2) inhibits HDAC6, activates autophagy and apoptosis and inhibits aggresome formation in hepatocellular carcinoma cells.

  2020cites this paper
• Valproic Acid Sensitizes Glioma Cells to Luteolin Through Induction of Apoptosis and Autophagy via Akt Signaling

  2020cites this paper
• The Anti-Tumorigenic Activity of Sema3C in the Chick Embryo Chorioallantoic Membrane Model

  2019cites this paper
• Hypoxia-derived exosomes induce putative altered pathways in biosynthesis and ion regulatory channels in glioblastoma cells

  2018cites this paper